Successful risperidone rechallenge after blepharospasm in a patient with schizophrenia: 24-month follow-up.
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001764:Blepharospasm / Q000139:chemically induced*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D018967:Risperidone